October 2011

Dear Colleagues:

The IASLC Board of Directors finalized in September a “Strategic Planning Document”. After several months of preparation the previous – and the current - BOD met with the external consultants during some days in Denver, Colorado to finalize the document (see below). The implementation and prioritizations will now be discussed with the IASLC BOD in tight collaboration with the different IASLC Committees. Of particularly emphasis in the new initiative is the integration of nurses, advocates and other healthcare professionals into the society, and a task force was established to formalize more interaction with industry.

The new IASLC committees have now been established after self-nomination and careful selection by the President by taking geography and expertise into account. New committees include separate committees for nurses and allied professionals, a patient advocate committee and a career development committee. The IASLC BOD is currently soliciting self nominations to the three committees.

The IASLC Headquarters in Denver, Colorado is per December 1, 2011 moving into a new rented location in a new building, next to the University of Colorado Denver, which also gives space for new technology and personnel expansion. 

The search for an IASLC CFO/COO has been completed and the IASLC is happy to welcome Mr. John Wetherington as our new CFO/COO. Mr. Wetherington will start per December 1, 2011 and will be introduced in our next Newsletter.

Fred R. Hirsch, MD, PhD
Editor, IASLC Newsletter

Strategic Plan



3rd ELCC (ESMO/IASLC) Lung Cancer Conference,
April 18 – 21, 2012, Geneva, Switzerland

 ELCC 2012

Abstracts deadline – January 11, 2012
For more information

5th Latin American Conference on Lung Cancer

 lalca 2012

The 5th Latin American Conference is now under planning and both an exciting educational – and scientific program have been developed, including sessions on the new staging, lung cancer screening and molecular testing for personalized medicine. Abstract deadline is March 30, 2012. For more information or


News from the South America Region:
By Dr. Eduardo Richardet, Regent of IASLC, Latin America

During 8 and 9th of September we have held the "Thorax Illnesses Symposium" at Hotel Meliá in Buenos Aires - Argentina. It was organized by FLASCA (Latin American Federation) and Hospital Italiano Buenos Aires. The multidisciplinary congress included the participation of renowned clinical oncologists, thoracic surgeons, neumonicists and radiotherapists and clinicians at the national and international levels, including countries such as USA, Spain, Uruguay and Brazil as well as Argentina.
The program included lectures about surgery, radiotherapy and oncological topics.

Dr. Bartomeu Massuti, from the Spanish Lung Cancer Group, lectured on personalized lung cancer treatment and showed to us the new tendencies and practices on lung cancer research. Additionally, Dr. Ramón Rami Porta from Spain lectured on the surgical procedures. His analysis of the new IASLC classification has been very relevant. Dr. Carlos Gil Ferreyra, from Brazil, shared his conclusions on monoclonal antibodies in lung cancer treatment. Dr. Eduardo Richardet, from Argentina, lectured on the new strategies in the patients that develop resistance to TKIs inhibitors.

Dr. Guadalupe Pallotta, David Smith and José María Lastiri presented many cases that were discussed during the two days in the multidisciplinary context. Dr. Henry Talezaar, from the Mayo Clinic in the US, presented the new challenges in pathologies.
Dr. Beatriz Améndola and Dr. Marco Améndola, from the Innovative Cancer Institute from the US, presented their findings on Innovative Radiotherapy. As regards Latin America Non-Small Cell Lung Cancer Forum 2011, held during 2nd-3rd September at Hotel Madero Puerto Madero, Buenos Aires Argentina. Dr. Mauro Orlando (Medical Director of Lilly) and Dr. Eduardo Richardet (IASLC Latin American Regent) chaired this symposium that was held in Hotel Madero, in Buenos Aires, Argentina. There were two special guests, Dr. Nicholas Thatcher, from England and Dr. Luis Paz Ares, from Spain, as well as numerous speakers from all the Latin American region (see their names in the attached file) and many important lung cancer oncologists from most of the South American countries. The current medical and oncological treatments were reviewed and discussed by these specialists. 

News from the Committees:
The Pathology Committee met recently in Tsukuba, Japan. Dr. Ming Tsao is appointed as new Chair of the Committee and follows Dr. Masayuki Noguchi, who will now be the Past Chair. The committee discussed the new strategic plan and how the committee can achieve its goals in harmony with the strategic plan. The committee also discussed how to implement and educate the new classification of adenocarcinomas. The committee will propose several new projects for the BOD, which includes further validation of the new adenocarcinoma and a new classification of nonadenocarcinoma tumors as well as molecular profiling of lung tumors to be integrated in a common data base for associations to stage, ethnicity, other demographic characteristics and prognosis.


IASLC Web-based Education Programs

IASLC has introduced new educational programs on its Web site ( for its members and for healthcare professionals who are managing patients with lung cancer. The first program titled, “New Developments in Non-Small Cell Lung Cancer” features Professor Peter Goldstraw, MD, in a two-part presentation, that reviews the fundamentals of the new lung cancer staging system and examines the role of the TNM staging system of patients with small-cell lung cancer. The new, updated IASLC nodal staging map is also reviewed. In another presentation, Paul Bunn, Jr, MD, addresses the incorporation of molecular testing into the standard diagnostic workup of patients with NSCLC, and the selection of appropriate treatment for patients. The program concludes with case-study presentations by Drs. Bunn and Harvey I. Pass, illustrating the use of the new staging system and molecular testing.

Upcoming webinars include: “Clinical Implications of the New Adenocarcinoma Classification”

IASLC Staging Manual:

The IASLC Staging Manual and Handbook in Thoracic Oncologic has now surpassed 35,000 copies sold worldwide. In addition, the Staging Posters and Reference Cards continue to be popular reference aids of the 7th edition staging system for practitioners and tumor boards. IASLC members can continue to order these publications and products at special member pricing (; contact for further information).

In addition, translations of these publications have been completed or are in process in multiple languages: Chinese, Italian, Japanese, Polish, and Turkish. Discussions about future translations in Spanish, Arabic, and Russian are ongoing.

Staging Manual

iPhone/iPAD Staging Atlas

The new IASLC Staging Manual has been published in different formats. Several years of work from the IASLC Staging Committee and particularly the chair Dr. Peter Goldstraw, has resulted in a formal staging manual. The book and the “pocket-cards” can be ordered at

JTO Mobile options

JTO is available for your iPhone, Blackberry, or Android phone, in a view designed for easy reading on a small screen. Type into your phone’s browser to access the site. You can view current issue table of contents, most viewed articles, most emailed articles, or search across issues. If you have created a user name and password on the desktop version of, you can use that same log in information to view full text articles, complete with illustrations.

IASLC Textbook – Editor in Chief: 
Harvey I. Pass, MD

Lung Cancer Book

Lung Cancer Book from Lippincott: The Fourth Edition of Principles and Practice of Lung Cancer, edited by Harvey I. Pass, MD et al is now available. For more information about the 1040 page book, with 330 illustrations (ISBN-10:0-7817-7365-2) or


Everette Vokes

Dr. Everett Vokes: Candidate for ASCO Presidency 2012 – 2014 One of our long term IASLC members, Dr. Everett Vokes from University of Chicago has been nominated as candidate for the ASCO Presidential Election 2012-2014. The election is currently ongoing. Please vote at

In Memoriam: Dr. Kiyoyuki Furuse (1933 – 2011)

Kiyoyuki Furuse

Dr. Kiyoyuki Furuse, MD, Kinki University Hospital, Osaka – passed away Dr. Kiyoyuki Furuse was a great mentor for many oncologists with attractive personality. He was a pioneer of clinical research and made a significant scientific contribution to development of lung cancer chemotherapy, particularly photo dynamic therapy (PDT) for the central type of early stage lung cancer and chemoradiotherapy for stage III non-small cell lung cancer. His most important work was “Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vinde- sine, and cisplatin in unresectable stage III non-small-cell lung cancer, published in J Clin Oncol 1999. Dr. Furuse also made a significant contribution to IASLC. Scientific program in the 9th World Conference of Lung Cancer in Tokyo was greatly supported by him.

Available position:
Research Pathologist: At the University of Colorado Cancer Center a position as a Research Pathologist is available. The pathologist will participate in research programs focusing on biomarker development and validation for early detection and treatment of lung cancer. The candidate should be board certified in pathology, but US certification is not required. For further information please contact: Fred R. Hirsch, MD, PhD, Professor of Medicine and Pathology, University of Colorado. E-mail:, ph. +1 303 724 3858.

Upcoming IASLC Workshops/Meetings 2011- 2015

JLCS/IASLC Joint Symposium
November 3-4, 2011
Osaka, Japan
More information:

1st reunion of the IASLC and the regency of Mexico and Central America
November 18, 2011, Cancun, Mexico
More information:

AACR-IASLC Joint Conference: Lung Cancer
January 8-12, 2012
Location: San Diego, California, U.S.A.

12th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting
February 22-25, 2012
Location: Santa Monica, California, U.S.A.

3rd European Lung Cancer Conference
April 18 - 21, 2012
Location: Geneva, Switzerland
More information:

5th Latin American Lung Cancer Conference
July 25-27, 2012
Location: Rio de Janeiro, Brazil
More information:

Chicago Multidisciplinary Symposium in Thoracic Oncology
September 6-8, 2012
Location: Hotel Marriott, Chicago, Illinois, U.S.A.
More information:

5th Asia Pacific Lung Cancer Conference
November 26-28, 2012
Location: Hilton Sea Hawk, Fukuoka, Japan
More information:

15th World Conference on Lung Cancer
October 27-31, 2013
Location: Sydney, Australia
More information:

16th World Conference on Lung Cancer
September 4-8, 2015
Location: Denver, Colorado, USA
More information: